Celldex Therapeutics reported $-81.32M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Agenus USD -10.61M 263.52M Dec/2025
Amgen USD 1.51B 2.41B Dec/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Celldex Therapeutics USD -81.32M 14.27M Dec/2025
Glaxosmithkline GBP 2.46B 569M Sep/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Pfizer USD 5.18B 6.82B Mar/2026
Rigel Pharmaceuticals USD -1.03M 7.22M Jun/2024
Roche Holding CHF 4.79B 3.01B Jun/2025